Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in RZLT — Rezolute, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in RZLT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$432,761
+$275,489 QoQ
Shares Held
141,889
+112.9% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Derivatives in RZLT

reported options exposure · as of Mar 31, 2026
CallValue
$2,697,725
CallShares
884,500
PutValue
$186,355
PutShares
61,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. RZLT ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RZLT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $432,761 141,889
2026-03-31 $2,697,725 884,500
2026-03-31 $186,355 61,100
2025-12-31 $837,564 354,900
2025-12-31 $140,184 59,400
2025-12-31 $157,272 66,641
2025-09-30 $595,161 63,315
2025-09-30 $2,595,340 276,100
2025-06-30 $362,892 81,366
2025-06-30 $1,114,554 249,900
2025-03-31 $2,687,305 926,657
2025-03-31 $583,190 201,100
2025-03-31 $51,910 17,900
2024-12-31 $4,378,644 893,601
2024-09-30 $510,472 105,252